SODIUM ACETATE INJ 328MG/ML USP 328 MG
SODIUM ACETATE : 328 MG · DIN 00780642 · SABEX INC
Health Canada status: CANCELLED POST MARKET
What is SODIUM ACETATE INJ 328MG/ML USP?
SODIUM ACETATE INJ 328MG/ML USP 328 MG contains SODIUM ACETATE : 328 MG. It is listed in the Health Canada Drug Product Database under DIN 00780642, held by SABEX INC, supplied as LIQUID for INTRAVENOUS administration. Health Canada currently lists it as cancelled post market, status dated 07-Aug-2008. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00780642 |
|---|---|
| Brand name | SODIUM ACETATE INJ 328MG/ML USP |
| Generic / active ingredient | SODIUM ACETATE : 328 MG |
| Manufacturer | SABEX INC |
| Strength | 328 MG |
| Dosage form | LIQUID |
| Route of administration | INTRAVENOUS |
| Schedule | Ethical |
| ATC code | B05XA08 SODIUM ACETATE |
| AHFS class | 40:12.00 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 07-Aug-2008 |
| Original market date | 1988-12-31 00:00:00 |
Is SODIUM ACETATE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by SANDOZ CANADA INCORPORATED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code B05XA08 SODIUM ACETATE. 2 of 5 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| SODIUM ACETATE INJECTION USP | 328 MG | Solution | OMEGA LABORATORIES LIMITED | MARKETED | DIN 02181746 |
| SODIUM ACETATE INJECTION, USP | 328 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | DIN 02139529 |
| 16.4% SODIUM ACETATE INJECTION, USP | 16.4 % | SOLUTION | BAXTER CORPORATION | CANCELLED POST MARKET | DIN 02247204 |
| SODIUM ACETATE INJ 328MG/ML USP | 328 MG | LIQUID | LYPHOMED, DIVISION OF FUJISAWA CANADA INC. | CANCELLED POST MARKET | DIN 01944843 |
Who else supplies SODIUM ACETATE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. SODIUM ACETATE appears in 5432 registered pack listings across 10 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.